Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Daniel Klintman"'
Publikováno v:
Alimentary Pharmacology & Therapeutics. 55:1389-1401
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33ff22491a775a9270c6349e7ad6e636
https://doi.org/10.1111/apt.16927
https://doi.org/10.1111/apt.16927
Publikováno v:
Alimentary pharmacologytherapeuticsREFERENCES. 56(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0bfbd57197f97f7fd29a70398ee067d
https://pubmed.ncbi.nlm.nih.gov/35934860
https://pubmed.ncbi.nlm.nih.gov/35934860
Publikováno v:
Alimentary Pharmacology & Therapeutics. 56:351-352
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8242879509dd9a5ec8e438e8868538a8
https://doi.org/10.1111/apt.17073
https://doi.org/10.1111/apt.17073
Autor:
Mattias Ekstedt, Nelson Ndegwa, Iris Posserud, Hannes Hagström, Johan Askling, Per Stål, Fredrik Rorsman, Hanns-Ulrich Marschall, Nils Nyhlin, Daniel Klintman, Mårten Werner, Molly Jalmeus
Publikováno v:
Liver international : official journal of the International Association for the Study of the LiverREFERENCES. 41(3)
Background & Aims Mutations in the HFE gene can lead to hereditary haemochromatosis (HH) and have been suggested to increase the risk of extra-hepatic diseases, especially breast and colorectal cancer. Here we investigated long-term outcomes of Swedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc52d32b21cc848e0742d1c5c9cc0690
https://pubmed.ncbi.nlm.nih.gov/33450138
https://pubmed.ncbi.nlm.nih.gov/33450138
Autor:
Inger Mattsby-Baltzer, Åsa Johansson, Daniel Klintman, Evangelos Kalaitzakis, Konstantina Sargenti, Sara Bertilsson
Publikováno v:
Digestive Diseases and Sciences. 61:2294-2302
Cirrhosis represents a state of functional immune paresis with increased infection risk.To investigate polymorphonuclear (PMN) leukocyte and monocyte function in ambulatory cirrhotics, and their potential relation with cirrhosis etiology or patient o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::723e4e21950e5f966a976ff4e12701ff
https://doi.org/10.1007/s10620-016-4132-3
https://doi.org/10.1007/s10620-016-4132-3
Autor:
Hannes Hagström, Nelson Ndegwa, Mattias Ekstedt, Iris Posserud, Fredrik Rorsman, Nils Nyhlin, Daniel Klintman, Mårten Werner, Hanns-Ulrich Marschall, Johan Askling, Per Stal
Publikováno v:
Journal of Hepatology. 73:S541
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e6fefba301f5f62d5e1e4c03ab21bad
https://doi.org/10.1016/s0168-8278(20)31555-5
https://doi.org/10.1016/s0168-8278(20)31555-5
Autor:
Mårten Werner, Hannes Hagström, Cumali Efe, Luigi Muratori, Naim Alkhouri, Tugrul Purnak, Thomas Berg, Paolo Muratori, Haider Al Taii, Thomas D. Schiano, Fin Stolze Larsen, Aldo J. Montano-Loza, Niklas Aehling, Eric M. Yoshida, Ersan Ozaslan, Rahima A. Bhanji, Michael A. Heneghan, Henriette Ytting, Staffan Wahlin, Daniel Klintman
Background: We studied the efficacy and safety of mycophenolate mofetil (MMF) and tacrolimus as second-line therapy in pediatric patients with autoimmune hepatitis (AIH) who were intolerant or non-responders to standard therapy (corticosteroid and az
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d87ff6af7610ea32078628ec9b10906
http://hdl.handle.net/11585/652853
http://hdl.handle.net/11585/652853
Autor:
Rahima A. Bhanji, Daniel Klintman, Hanns-Ulrich Marschall, Eric M. Yoshida, Albert Parés, Thomas D. Schiano, Aldo J. Montano-Loza, Niklas F. Müller, Fin Stolze Larsen, Mustafa Cengiz, Cumali Efe, Mårten Werner, Xiong Ma, Fulya Gunsar, Tugrul Purnak, Hannes Hagström, Henriette Ytting, Michael A. Heneghan, Staffan Wahlin, Michele M. Tana, Qixia Wang, Sumita Verma, Ersan Ozaslan, Luigi Muratori, Paolo Muratori, Thomas Berg, Alexandra Heurgué-Berlot
Publikováno v:
Efe, C, Hagström, H, Ytting, H, Bhanji, R A, Müller, N F, Wang, Q, Purnak, T, Muratori, L, Werner, M, Marschall, H U, Muratori, P, Gunşar, F, Klintman, D, Parés, A, Heurgué-Berlot, A, Schiano, T D, Cengiz, M, May-Sien Tana, M, Ma, X, Montano-Loza, A J, Berg, T, Verma, S, Larsen, F S, Ozaslan, E, Heneghan, M A, Yoshida, E M & Wahlin, S 2017, ' Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis ', Clinical Gastroenterology and Hepatology, vol. 15, no. 12, pp. 1950-1956.e1 . https://doi.org/10.1016/j.cgh.2017.06.001
Efe, C, Hagström, H, Ytting, H, Bhanji, R A, Müller, N F, Wang, Q, Purnak, T, Muratori, L, Werner, M, Marschall, H-U, Muratori, P, Gunşar, F, Klintman, D, Parés, A, Heurgué–Berlot, A, Schiano, T D, Cengiz, M, May-Sien Tana, M, Ma, X, Montano-Loza, A J, Berg, T, Verma, S, Larsen, F S, Ozaslan, E, Heneghan, M A, Yoshida, E M & Wahlin, S 2017, ' Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients with Autoimmune Hepatitis ', CLINICAL GASTROENTEROLOGY AND HEPATOLOGY . https://doi.org/10.1016/j.cgh.2017.06.001
Efe, C, Hagström, H, Ytting, H, Bhanji, R A, Müller, N F, Wang, Q, Purnak, T, Muratori, L, Werner, M, Marschall, H-U, Muratori, P, Gunşar, F, Klintman, D, Parés, A, Heurgué–Berlot, A, Schiano, T D, Cengiz, M, May-Sien Tana, M, Ma, X, Montano-Loza, A J, Berg, T, Verma, S, Larsen, F S, Ozaslan, E, Heneghan, M A, Yoshida, E M & Wahlin, S 2017, ' Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients with Autoimmune Hepatitis ', CLINICAL GASTROENTEROLOGY AND HEPATOLOGY . https://doi.org/10.1016/j.cgh.2017.06.001
WOS: 000415165200027
PubMed ID: 28603052
BACKGROUND & AIMS: Predniso(lo) ne, alone or in combination with azathioprine, is the standard-of-care (SOC) therapy for autoimmune hepatitis (AIH). However, the SOC therapy is poorly tolerated or do
PubMed ID: 28603052
BACKGROUND & AIMS: Predniso(lo) ne, alone or in combination with azathioprine, is the standard-of-care (SOC) therapy for autoimmune hepatitis (AIH). However, the SOC therapy is poorly tolerated or do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e7c7514288c18abc34179fb46af910a
https://hdl.handle.net/11454/31474
https://hdl.handle.net/11454/31474
Autor:
Per Hammarlund, Ragnar Befrits, Håkan Blom, Antal Bajor, Ola Wikman, Daniel Klintman, Lars Blomquist, Henrik Hjortswang
Publikováno v:
Scandinavian Journal of Gastroenterology. 48:1027-1032
Iron deficiency and anemia are being increasingly recognized as a complication of inflammatory bowel disease (IBD). The aim of this study was to observe, in a non-interventional way, how Swedish gastroenterologists adhere to guidelines in IBD outpati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::968d2bb0f5ba7d5cf3d893fa05785f89
https://doi.org/10.3109/00365521.2013.819442
https://doi.org/10.3109/00365521.2013.819442
Autor:
René Schramm, Daniel Klintman, Tohru Sato, Gunnar Hedlund, Bengt Jeppsson, Henrik Thorlacius, Xiang Li
Publikováno v:
British Journal of Pharmacology. 143:865-871
1 The immunomodulator Linomide has been shown to protect against septic liver injury by reducing hepatic accumulation of leukocytes although the detailed anti-inflammatory mechanisms remain elusive. This study examined the effect of Linomide on the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d7b8594c77b1918fab7061928c847b65
https://doi.org/10.1038/sj.bjp.0706015
https://doi.org/10.1038/sj.bjp.0706015